Autologous Stem Cell & Non-Stem Cell Based Therapies
SKU
MRR-030C42D3EDB5
Region
Global
Publication Date
February 2024
Delivery
Immediate
2023
USD 7.17 billion
2030
USD 18.83 billion
2024
USD 8.22 billion
CAGR
14.78%
Autologous Stem Cell & Non-Stem Cell Based Therapies Market by Type (Autologous Non-Stem Cells, Autologous Stem Cells), Indication (Cancer, Cardiovascular Disease, Neurodegenerative Disorders), End-User - Global Forecast 2024-2030

[191 Pages Report] The Autologous Stem Cell & Non-Stem Cell Based Therapies Market size was estimated at USD 7.17 billion in 2023 and expected to reach USD 8.22 billion in 2024, at a CAGR 14.78% to reach USD 18.83 billion by 2030.

Autologous Stem Cell & Non-Stem Cell Based Therapies Market
To learn more about this report, request a free sample copy
Autologous Stem Cell & Non-Stem Cell Based Therapies Market - Global Forecast 2024-2030
To learn more about this report, request a free sample copy
FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Autologous Stem Cell & Non-Stem Cell Based Therapies Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Autologous Stem Cell & Non-Stem Cell Based Therapies Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Autologous Stem Cell & Non-Stem Cell Based Therapies Market, highlighting leading vendors and their innovative profiles. These include Brainstorm Cell Therapeutics, Inc., Castle Creek Biosciences Inc., Cytori Therapeutics Inc., Dendreon Pharmaceuticals LLC, Gilead Sciences, Inc., HCA International Limited, Hemogenyx Pharmaceuticals PLC, Hemostemix Inc., Jasper Therapeutics, Inc., NOVADIP Biosciences S.A., Novartis AG, Opexa Therapeutics, Inc., Regeneus Ltd., and Takeda Pharmaceutical Company Limited.

Market Segmentation & Coverage

This research report categorizes the Autologous Stem Cell & Non-Stem Cell Based Therapies Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Autologous Non-Stem Cells
    • Autologous Stem Cells
  • Indication
    • Cancer
    • Cardiovascular Disease
    • Neurodegenerative Disorders
    • Orthopedic Diseases
  • End-User
    • Ambulatory Surgical Centers
    • Hospitals
    • Research Facilities

  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Autologous Stem Cell & Non-Stem Cell Based Therapies Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Autologous Stem Cell & Non-Stem Cell Based Therapies Market?
  3. What are the technology trends and regulatory frameworks in the Autologous Stem Cell & Non-Stem Cell Based Therapies Market?
  4. What is the market share of the leading vendors in the Autologous Stem Cell & Non-Stem Cell Based Therapies Market?
  5. Which modes and strategic moves are suitable for entering the Autologous Stem Cell & Non-Stem Cell Based Therapies Market?

  1. Preface
    1. Objectives of the Study
    2. Market Segmentation & CoverageAUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SEGMENTATION & COVERAGE
    3. Years Considered for the Study
    4. Currency & PricingUNITED STATES DOLLAR EXCHANGE RATE, 2018–2023
    5. Language
    6. Limitations
    7. Assumptions
    8. Stakeholders
  2. Research Methodology
    1. AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET RESEARCH PROCESS
    2. Define: Research Objective
    3. Determine: Research Design
    4. Prepare: Research Instrument
    5. Collect: Data Source
    6. Analyze: Data Interpretation
    7. Formulate: Data Verification
    8. Publish: Research Report
    9. Repeat: Report Update
  3. Executive Summary
    1. AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2023 VS 2030
  4. Market Overview
    1. IntroductionAUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2018-2030 (USD MILLION)AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2018-2030 (USD MILLION)
    2. Autologous Stem Cell & Non-Stem Cell Based Therapies Market, by RegionAUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY REGION, 2023 VS 2030 (%)AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  5. Market Insights
    1. Market DynamicsAUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET DYNAMICS
      1. Drivers
        1. Rise in the prevalence of cancer and diabetes among population
        2. Increased demand to manage a large number of infectious diseases
        3. Advantage of intensive therapy for older patients
      2. Restraints
        1. High costs associated with autologous stem cell & non-stem cell therapies
      3. Opportunities
        1. Rise in investment for extensive research and development
        2. Advances in treating various diseases, neurodegenerative diseases and macular degeneration
      4. Challenges
        1. Risks and complications associated with the therapy
    2. Market Segmentation Analysis
    3. Market Trend Analysis
    4. Cumulative Impact of High Inflation
    5. Porter’s Five Forces Analysis
      1. Threat of New Entrants
      2. Threat of Substitutes
      3. Bargaining Power of Customers
      4. Bargaining Power of Suppliers
      5. Industry Rivalry
    6. Value Chain & Critical Path Analysis
    7. Regulatory Framework
  6. Autologous Stem Cell & Non-Stem Cell Based Therapies Market, by Type
    1. IntroductionAUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
    2. Autologous Non-Stem CellsAUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY AUTOLOGOUS NON-STEM CELLS, BY , 2018-2030 (USD MILLION)
    3. Autologous Stem CellsAUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY AUTOLOGOUS STEM CELLS, BY , 2018-2030 (USD MILLION)
  7. Autologous Stem Cell & Non-Stem Cell Based Therapies Market, by Indication
    1. IntroductionAUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
    2. CancerAUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY CANCER, BY , 2018-2030 (USD MILLION)
    3. Cardiovascular DiseaseAUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY , 2018-2030 (USD MILLION)
    4. Neurodegenerative DisordersAUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY NEURODEGENERATIVE DISORDERS, BY , 2018-2030 (USD MILLION)
    5. Orthopedic DiseasesAUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY ORTHOPEDIC DISEASES, BY , 2018-2030 (USD MILLION)
  8. Autologous Stem Cell & Non-Stem Cell Based Therapies Market, by End-User
    1. IntroductionAUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    2. Ambulatory Surgical CentersAUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY , 2018-2030 (USD MILLION)
    3. HospitalsAUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY HOSPITALS, BY , 2018-2030 (USD MILLION)
    4. Research FacilitiesAUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY RESEARCH FACILITIES, BY , 2018-2030 (USD MILLION)
  9. Americas Autologous Stem Cell & Non-Stem Cell Based Therapies Market
    1. Introduction
    2. AMERICAS AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)AMERICAS AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)AMERICAS AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    3. AMERICAS AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)AMERICAS AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)AMERICAS AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
    4. Argentina
    5. ARGENTINA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)ARGENTINA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)ARGENTINA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    6. Brazil
    7. BRAZIL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)BRAZIL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)BRAZIL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    8. Canada
    9. CANADA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)CANADA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)CANADA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    10. Mexico
    11. MEXICO AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)MEXICO AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)MEXICO AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    12. United States
    13. UNITED STATES AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)UNITED STATES AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)UNITED STATES AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    14. UNITED STATES AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY STATE, 2023 VS 2030 (%)UNITED STATES AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)UNITED STATES AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  10. Asia-Pacific Autologous Stem Cell & Non-Stem Cell Based Therapies Market
    1. Introduction
    2. ASIA-PACIFIC AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)ASIA-PACIFIC AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)ASIA-PACIFIC AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    3. ASIA-PACIFIC AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)ASIA-PACIFIC AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)ASIA-PACIFIC AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
    4. Australia
    5. AUSTRALIA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)AUSTRALIA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)AUSTRALIA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    6. China
    7. CHINA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)CHINA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)CHINA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    8. India
    9. INDIA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)INDIA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)INDIA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    10. Indonesia
    11. INDONESIA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)INDONESIA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)INDONESIA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    12. Japan
    13. JAPAN AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)JAPAN AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)JAPAN AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    14. Malaysia
    15. MALAYSIA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)MALAYSIA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)MALAYSIA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    16. Philippines
    17. PHILIPPINES AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)PHILIPPINES AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)PHILIPPINES AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    18. Singapore
    19. SINGAPORE AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)SINGAPORE AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)SINGAPORE AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    20. South Korea
    21. SOUTH KOREA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)SOUTH KOREA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)SOUTH KOREA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    22. Taiwan
    23. TAIWAN AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)TAIWAN AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)TAIWAN AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    24. Thailand
    25. THAILAND AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)THAILAND AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)THAILAND AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    26. Vietnam
    27. VIETNAM AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)VIETNAM AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)VIETNAM AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  11. Europe, Middle East & Africa Autologous Stem Cell & Non-Stem Cell Based Therapies Market
    1. Introduction
    2. EUROPE, MIDDLE EAST & AFRICA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)EUROPE, MIDDLE EAST & AFRICA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)EUROPE, MIDDLE EAST & AFRICA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    3. EUROPE, MIDDLE EAST & AFRICA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)EUROPE, MIDDLE EAST & AFRICA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)EUROPE, MIDDLE EAST & AFRICA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
    4. Denmark
    5. DENMARK AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)DENMARK AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)DENMARK AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    6. Egypt
    7. EGYPT AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)EGYPT AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)EGYPT AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    8. Finland
    9. FINLAND AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)FINLAND AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)FINLAND AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    10. France
    11. FRANCE AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)FRANCE AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)FRANCE AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    12. Germany
    13. GERMANY AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)GERMANY AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)GERMANY AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    14. Israel
    15. ISRAEL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)ISRAEL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)ISRAEL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    16. Italy
    17. ITALY AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)ITALY AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)ITALY AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    18. Netherlands
    19. NETHERLANDS AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)NETHERLANDS AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)NETHERLANDS AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    20. Nigeria
    21. NIGERIA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)NIGERIA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)NIGERIA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    22. Norway
    23. NORWAY AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)NORWAY AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)NORWAY AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    24. Poland
    25. POLAND AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)POLAND AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)POLAND AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    26. Qatar
    27. QATAR AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)QATAR AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)QATAR AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    28. Russia
    29. RUSSIA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)RUSSIA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)RUSSIA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    30. Saudi Arabia
    31. SAUDI ARABIA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)SAUDI ARABIA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)SAUDI ARABIA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    32. South Africa
    33. SOUTH AFRICA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)SOUTH AFRICA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)SOUTH AFRICA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    34. Spain
    35. SPAIN AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)SPAIN AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)SPAIN AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    36. Sweden
    37. SWEDEN AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)SWEDEN AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)SWEDEN AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    38. Switzerland
    39. SWITZERLAND AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)SWITZERLAND AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)SWITZERLAND AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    40. Turkey
    41. TURKEY AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)TURKEY AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)TURKEY AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    42. United Arab Emirates
    43. UNITED ARAB EMIRATES AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)UNITED ARAB EMIRATES AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)UNITED ARAB EMIRATES AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
    44. United Kingdom
    45. UNITED KINGDOM AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)UNITED KINGDOM AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)UNITED KINGDOM AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  12. Competitive Landscape
    1. FPNV Positioning MatrixAUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET, FPNV POSITIONING MATRIX, 2023AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET, FPNV POSITIONING MATRIX, 2023
    2. Market Share Analysis, By Key PlayerAUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SHARE, BY KEY PLAYER, 2023AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SHARE, BY KEY PLAYER, 2023
    3. Competitive Scenario Analysis, By Key Player
  13. Competitive Portfolio
    1. Key Company Profiles
      1. Brainstorm Cell Therapeutics, Inc.
      2. Castle Creek Biosciences Inc.
      3. Cytori Therapeutics Inc.
      4. Dendreon Pharmaceuticals LLC
      5. Gilead Sciences, Inc.
      6. HCA International Limited
      7. Hemogenyx Pharmaceuticals PLC
      8. Hemostemix Inc.
      9. Jasper Therapeutics, Inc.
      10. NOVADIP Biosciences S.A.
      11. Novartis AG
      12. Opexa Therapeutics, Inc.
      13. Regeneus Ltd.
      14. Takeda Pharmaceutical Company Limited
    2. Key Product Portfolio
  1. Brainstorm Cell Therapeutics, Inc.
  2. Castle Creek Biosciences Inc.
  3. Cytori Therapeutics Inc.
  4. Dendreon Pharmaceuticals LLC
  5. Gilead Sciences, Inc.
  6. HCA International Limited
  7. Hemogenyx Pharmaceuticals PLC
  8. Hemostemix Inc.
  9. Jasper Therapeutics, Inc.
  10. NOVADIP Biosciences S.A.
  11. Novartis AG
  12. Opexa Therapeutics, Inc.
  13. Regeneus Ltd.
  14. Takeda Pharmaceutical Company Limited
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analysis to market estimates & forecasts. See for yourself.
Frequently Asked Questions about the Autologous Stem Cell & Non-Stem Cell Based Therapies Market
The Global Autologous Stem Cell & Non-Stem Cell Based Therapies Market size was estimated at USD 7.17 billion in 2023 and expected to reach USD 8.22 billion in 2024.
The Global Autologous Stem Cell & Non-Stem Cell Based Therapies Market to grow USD 18.83 billion by 2030, at a CAGR of 14.78%
Most reports are fulfilled immediately. In some cases, it could take up to 2 business days.
We will send you an email with login credentials to access the report. You will also be able to download the pdf and excel.
We are approaching our 7th anniversary in 2024!
Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available and included in every purchase to help our customers find the research they need-when they need it.
Absolutely yes, with the purchase of additional user licenses.
Absolutely yes, so long as the 360iResearch cited correctly.